Trends in sinusitis research: a systematic review of extramural funding.

TitleTrends in sinusitis research: a systematic review of extramural funding.
Publication TypeJournal Article
Year of Publication2017
AuthorsLevy JM, Smith SShintani, Varshney R, Chang EH, Ramakrishnan VR, Ting JY, Bleier BS
JournalInt Forum Allergy Rhinol
Volume7
Issue11
Pagination1104-1107
Date Published2017 11
ISSN2042-6984
KeywordsBiomedical Research, Humans, National Institutes of Health (U.S.), Research Support as Topic, Sinusitis, United States
Abstract

BACKGROUND: Innovation represents a core value of the American Rhinologic Society (ARS), with multiple efforts to promote research in the advancement rhinologic care. We therefore sought to identify trends in extramural sinusitis funding and underutilized sources of support to facilitate future efforts.

METHODS: A systematic review of the National Institutes of Health (NIH) Research Portfolio Online Tools (RePORTER) database (fiscal year 1993 to 2017) was completed with the search strategy: ("chronic sinusitis" OR rhinosinusitis). All identified studies were accepted for review, with comparison to ARS membership rolls to identify studies supported by ARS investigators. Foundation awards were surveyed to identify and characterize additional sources of support.

RESULTS: The systematic review identified 958 projects receiving NIH funding, of which 120 remain active. The percentage of sinusitis-related awards and total funding relative to all NIH awards increased over the past 10 years (2006 to 2016) from 0.06% (8 / 9128) and 0.09% ($2,151,152 / $3,358,338,602) to 0.87% (86 / 9540) and 0.90% ($37,201,095 / $4,300,145,614). Among active studies, 9 investigators maintain membership in the ARS and serve as principal investigator or project leader in 12 (10%) studies. ARS investigators received the greatest number of awards from the National Institute on Deafness and Other Communication Disrders (n = 8,66.7%), while only receiving 2.2% of awarded funding from the National Institute of Allergy and Infectious Diseases ($607,500/$26,873,022), the largest source of awards for sinusitis research.

CONCLUSION: Support for sinusitis research is significantly growing, with the largest source of active funding not being fully utilized by members of the ARS. Further efforts to promote funding priorities among extramural sources is necessary to facilitate increased funding for ARS member initiatives.

DOI10.1002/alr.22015
Alternate JournalInt Forum Allergy Rhinol
PubMed ID28985031
Faculty Reference: 
Eugene H. Chang, MD